Filing Details
- Accession Number:
- 0001209191-19-045633
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-12 19:08:47
- Reporting Period:
- 2019-08-08
- Accepted Time:
- 2019-08-12 19:08:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1333482 | J Kimberly Popovits | 301 Penobscot Dr. Redwood City CA 94063 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-05-29 | 800 | $0.00 | 108,152 | No | 5 | G | Indirect | Held by the Popovits 2010 Trust |
Common Stock | Acquisiton | 2019-08-08 | 25,000 | $29.34 | 133,468 | No | 4 | M | Indirect | Held by the Popovits 2010 Trust |
Common Stock | Disposition | 2019-08-08 | 15,765 | $73.63 | 117,703 | No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
Common Stock | Disposition | 2019-08-08 | 9,235 | $74.23 | 108,468 | No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
Common Stock | Acquisiton | 2019-08-09 | 25,000 | $29.34 | 133,468 | No | 4 | M | Indirect | Held by the Popovits 2010 Trust |
Common Stock | Disposition | 2019-08-09 | 24,000 | $73.63 | 109,468 | No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
Common Stock | Disposition | 2019-08-09 | 1,000 | $74.37 | 108,468 | No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Indirect | Held by the Popovits 2010 Trust |
No | 4 | M | Indirect | Held by the Popovits 2010 Trust |
No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
No | 4 | M | Indirect | Held by the Popovits 2010 Trust |
No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
No | 4 | S | Indirect | Held by the Popovits 2010 Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-08-08 | 25,000 | $0.00 | 25,000 | $29.34 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-08-09 | 25,000 | $0.00 | 25,000 | $29.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
65,000 | 2022-02-05 | No | 4 | M | Direct | |
40,000 | 2022-02-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 12,298 | Indirect | Held by Morgan Stanley as Custodian for Benefit of Kimberly Popovits |
Common Stock | 36,168 | Direct |
Footnotes
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $73.03 to $74.02.
- Represents weighted average sale price. Actual sale prices ranged from $74.03 to $74.39.
- Represents weighted average sale price. Actual sale prices ranged from $73.24 to $74.15.
- Represents weighted average sale price. Actual sale prices ranged from $74.24 to $74.45.
- Represents shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- The option became exercisable as to 25% of the shares on February 5, 2013, and became exercisable as to 1/48th of the shares each full month thereafter.